Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Sharing unexpected biomarker results with study participants.

Hernick AD, Brown MK, Pinney SM, Biro FM, Ball KM, Bornschein RL.

Environ Health Perspect. 2011 Jan;119(1):1-5. doi: 10.1289/ehp.1001988. Epub 2010 Sep 29.

2.

Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure.

Gallo V, Leonardi G, Genser B, Lopez-Espinosa MJ, Frisbee SJ, Karlsson L, Ducatman AM, Fletcher T.

Environ Health Perspect. 2012 May;120(5):655-60. doi: 10.1289/ehp.1104436. Epub 2012 Jan 30.

3.

Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters.

Emmett EA, Zhang H, Shofer FS, Freeman D, Rodway NV, Desai C, Shaw LM.

J Occup Environ Med. 2006 Aug;48(8):771-9.

4.

Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population.

Midasch O, Schettgen T, Angerer J.

Int J Hyg Environ Health. 2006 Nov;209(6):489-96. Epub 2006 Jul 26.

PMID:
16872899
5.

Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project.

Shin HM, Vieira VM, Ryan PB, Steenland K, Bartell SM.

Environ Health Perspect. 2011 Dec;119(12):1760-5. doi: 10.1289/ehp.1103729. Epub 2011 Aug 3. Erratum in: Environ Health Perspect.2013 Apr;121(4):A113.

6.

Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011.

Toms LM, Thompson J, Rotander A, Hobson P, Calafat AM, Kato K, Ye X, Broomhall S, Harden F, Mueller JF.

Environ Int. 2014 Oct;71:74-80. doi: 10.1016/j.envint.2014.05.019. Epub 2014 Jun 27.

7.

PFOS and PFOA in paired urine and blood from general adults and pregnant women: assessment of urinary elimination.

Zhang T, Sun H, Qin X, Gan Z, Kannan K.

Environ Sci Pollut Res Int. 2015 Apr;22(7):5572-9. doi: 10.1007/s11356-014-3725-7. Epub 2014 Nov 5.

PMID:
25367642
8.

Perfluorinated compounds in serum and urine samples from children aged 5-13 years in South Korea.

Kim DH, Lee MY, Oh JE.

Environ Pollut. 2014 Sep;192:171-8. doi: 10.1016/j.envpol.2014.05.024. Epub 2014 Jun 19.

PMID:
24952613
9.

Biomonitoring of perfluoroalkyl acids in human urine and estimates of biological half-life.

Zhang Y, Beesoon S, Zhu L, Martin JW.

Environ Sci Technol. 2013 Sep 17;47(18):10619-27. doi: 10.1021/es401905e. Epub 2013 Aug 27.

PMID:
23980546
10.

Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives.

Olsen GW, Butenhoff JL, Zobel LR.

Reprod Toxicol. 2009 Jun;27(3-4):212-30. doi: 10.1016/j.reprotox.2009.02.001. Epub 2009 Feb 20. Review.

PMID:
19429401
11.

Brominated flame retardants and perfluorinated chemicals, two groups of persistent contaminants in Belgian human blood and milk.

Roosens L, D'Hollander W, Bervoets L, Reynders H, Van Campenhout K, Cornelis C, Van Den Heuvel R, Koppen G, Covaci A.

Environ Pollut. 2010 Aug;158(8):2546-52. doi: 10.1016/j.envpol.2010.05.022. Epub 2010 Jun 22.

PMID:
20573431
12.

Isomers of perfluorooctanesulfonate and perfluorooctanoate and total perfluoroalkyl acids in human serum from two cities in North China.

Zhang Y, Beesoon S, Zhu L, Martin JW.

Environ Int. 2013 Mar;53:9-17. doi: 10.1016/j.envint.2012.12.007. Epub 2013 Jan 8.

PMID:
23314039
13.

The influence of time, sex and geographic factors on levels of perfluorooctane sulfonate and perfluorooctanoate in human serum over the last 25 years.

Harada K, Saito N, Inoue K, Yoshinaga T, Watanabe T, Sasaki S, Kamiyama S, Koizumi A.

J Occup Health. 2004 Mar;46(2):141-7.

14.

Consumption of seafood, serum liver enzymes, and blood levels of PFOS and PFOA in the Japanese population.

Yamaguchi M, Arisawa K, Uemura H, Katsuura-Kamano S, Takami H, Sawachika F, Nakamoto M, Juta T, Toda E, Mori K, Hasegawa M, Tanto M, Shima M, Sumiyoshi Y, Morinaga K, Kodama K, Suzuki T, Nagai M, Satoh H.

J Occup Health. 2013;55(3):184-94. Epub 2013 Apr 9.

15.

Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community.

Seals R, Bartell SM, Steenland K.

Environ Health Perspect. 2011 Jan;119(1):119-24. doi: 10.1289/ehp.1002346. Epub 2010 Sep 22.

16.

Serum biomarkers of polyfluoroalkyl compound exposure in young girls in Greater Cincinnati and the San Francisco Bay Area, USA.

Pinney SM, Biro FM, Windham GC, Herrick RL, Yaghjyan L, Calafat AM, Succop P, Sucharew H, Ball KM, Kato K, Kushi LH, Bornschein R.

Environ Pollut. 2014 Jan;184:327-34. doi: 10.1016/j.envpol.2013.09.008. Epub 2013 Oct 1.

17.

Background levels of persistent organic pollutants in humans from Taiwan: perfluorooctane sulfonate and perfluorooctanoic acid.

Hsu JY, Hsu JF, Ho HH, Chiang CF, Liao PC.

Chemosphere. 2013 Sep;93(3):532-7. doi: 10.1016/j.chemosphere.2013.06.047. Epub 2013 Jul 22.

PMID:
23886440
18.

Relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother-child pairs in a population with perfluorooctanoate exposure from drinking water.

Mondal D, Lopez-Espinosa MJ, Armstrong B, Stein CR, Fletcher T.

Environ Health Perspect. 2012 May;120(5):752-7. doi: 10.1289/ehp.1104538. Epub 2012 Jan 23.

19.

Perfluorinated compounds in human blood around Bohai Sea, China.

Guo F, Zhong Y, Wang Y, Li J, Zhang J, Liu J, Zhao Y, Wu Y.

Chemosphere. 2011 Sep;85(2):156-62. doi: 10.1016/j.chemosphere.2011.06.038. Epub 2011 Jul 2.

PMID:
21724231
20.

Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources.

Emmett EA, Shofer FS, Zhang H, Freeman D, Desai C, Shaw LM.

J Occup Environ Med. 2006 Aug;48(8):759-70.

Supplemental Content

Support Center